Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-01
2000-04-11
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546112, C07D47104, A61K 31435
Patent
active
060488700
ABSTRACT:
The invention relates to novel 3, 5, and/or 6 swainsonine analogues, processes for their preparation and their use as therapeutic agents. The invention also relates to pharmaceutical compositions containing the compounds and their use as therapeutics.
REFERENCES:
patent: 3274202 (1966-09-01), Mohrbacher
patent: 4792558 (1988-12-01), Sunkara et al.
patent: 4837237 (1989-06-01), Rohrschneider et al.
patent: 4857315 (1989-08-01), Dennis
patent: 4894388 (1990-01-01), Fleet
patent: 4996329 (1991-02-01), Fleet et al.
patent: 5021427 (1991-06-01), Elbein et al.
patent: 5023340 (1991-06-01), Fleet
patent: 5041555 (1991-08-01), Fleet et al.
patent: 5075448 (1991-12-01), Fleet
patent: 5075457 (1991-12-01), Fleet
patent: 5187279 (1993-02-01), Cha et al.
patent: 5264356 (1993-11-01), Rohrschneider
patent: 5272070 (1993-12-01), Lehrman et al.
patent: 5288875 (1994-02-01), Cha et al.
patent: 5376675 (1994-12-01), Alphey et al.
patent: 5382709 (1995-01-01), Farr et al.
patent: 5438069 (1995-08-01), Farr et al.
patent: 5466809 (1995-11-01), Dime
patent: 5484925 (1996-01-01), Cha et al.
patent: 5621106 (1997-04-01), Dime
patent: 5633261 (1997-05-01), Dime
patent: 5650413 (1997-07-01), Carver et al.
patent: 5780633 (1998-07-01), Okada et al.
Dennis J. W. in "Cell Surface Carbohydrates and Cell Development", Fukuda M.(ed)., CRC Press, Boca Raton, Ann Arbor London, 1992, Chapter 6, pp. 161-194.
Dennis J. W. et al, Science, 236:582, 1987.
VanderElst, E. and J.W. Dennis, Experimental Cell Research 192: 612-621, 1991.
J.W. Dennis, Cancer Research 46:5131, 1986.
Humphries, M.J. et al, Proc.Natl. Acad, Sci, USA, 83:1752, 1986.
Colegate S.M. et al., Aust. J. Chem. 1979, 32: 2257-64, 1979.
Molyneux R.J. and L.F. James, Science 216:190, Apr. 1982.
Schneider M.J. et al, Tetrahedron 39(1):29, 1983.
Tulsiani D.R.P. et al, J. Biol. Chem. 257:7936, 1982.
Fernandes, B. et al, Cancer Research 51: 718, 1991.
Olden K. et al, Pharmac. Ther. 50:285, 1991.
Humphries, M.J. et al, Cancer Research 48:1410, 1988.
M. Yagita and E. Sakela, Scand. J. Immunol 31:275-282, 1990.
White, S.L. et al, Biochem Biophys. Res. Commun. 150:615-625, 1988.
Seftor, R.E.B. Melanoma Research 1:43-54, 1991.
Yagel S., et al., Intl. J. Cancer 44:685, 1989.
J.W. Dennis et al, J. Natinal Cancer Institute 81:1028, 1989.
J.W. Dennis et al, Cancer Research 50:1867, 1990.
Humphries, M.J. and K. Olden, Pharmac. Ther. 44:85-105, 1989.
White, S.L. et al., Cancer Communications, 3(30):83, 1991.
Oredipe, O.A., et al, J. National Cancer Institute, 83:1149, 1991.
J.W. Dennis, et al, Biochemical Pharmacology 46:1459, 1993.
Aoyama, H. et al, J. Org. Chem. 57:3027-3041, 1992.
Hibbett, E. P., and J. Sam, J. Het. Chem. 7:857,1970.
Heidt, P.C. et al, Tetrahedron Letters 31: 5441, 1990.
Reinecke, M., and L.R. Kray, J. Org. Chem. 29: 1736, 1964.
Chastanet, J. and G. Roussi, J. Org, Chem, 50:2910-2914, 1985.
Bashyal, B.P. et al, Tetrahedron Letters, 3083,1987.
Clemo, G.R. and T.P. Metcalfe, J. Chem. Soc. 1937, p. 1518.
Leonard, N.J. et al, J. Org. Chem. 22:1445, 1957.
Winkler D.A. and G. Holan, J. Med. Chem., 32:2084, 1989.
Reinecke, M.G. and L.R. Kray, J. Org. Chem 30:3671, 1965.
Bogeso, K.P. et al, J. Med. Chem. 30:142-150, 1987.
Goss P.E. et al, Cancer Res. 54: 1450, 1994.
Hino et al, J. Antibiot. (Tokyo) 38: 926-935, 1985.
Goss, P.E. et al, Clin. Cancer Res. 3:1077,1997.
Holden R.T. and R. Raper, J. Chem. Soc. p. 2545, 1963.
Biniecki S. et al., Chemical Abstracts, 1984, 101, No. 90743a.
Biniecki, S. et al., Chemical Abstracts, 106, 1987, 138204h.
Boegesoe, K. P., et al., Chemical Abstracts, 106, 1987, No. 84369v.
Smith, M.B. et al., Chemical Abstracts vol. 104, 1986, No. 51007f.
Hashimoto, S. et al., Chemical Abstracts vol. 106, 1987, No. 138253y.
Miyano, Se. et al, Chemical Abstracts, vol. 98, 1983, No. 179148c.
Yoon, U.C. et al., Chemical Abstracts vol. 97, 1982, No. 38827r.
Fujiwara, et al, Chemical Abstracts vol. 117, 1992, No. 211862e.
Winterfeld, K. et al., Chemical Abstracts vol. 74, 1971, No. 3456s.
Motohiro, et al., Chemical Abstracts vol. 101, Abstract 28283x, 1984.
Temple Jr. C. and G. Rener, J. Med Chem 32:2089, 1989.
Nicolson, G.L. Biochem Biophys. Acta. 695:113, 1982.
Tulsiani, D.R.P. et al., Archives Biochem. Biophys. 232: 76-85, 1984.
Levine, A.S. et al., Can. Res. 39: 1645-1650, 1970.
Bowlin, T.L. et al., Cancer Research 49:4109-4113, 1989.
Tulsiani, D.R.P. and O. Touster, J. Biol. Chem., 258: 7578-7585, 1983.
S.R. Wilson and R.A. Sawicki J. Org. Chem 44:330, 1979.
Villiani et al, J. Org. Chem., 6:142, 1962.
Austin, G.N. et al, Tetrahedron, 43:3095-3108, 1987.
Skelton, B.W. and White, A.H., Aust. J. Chem. 33:435-9, 1980.
Pearson, W. H. and E.J. Hembre, J. Org. Chem. 61:5546-5556, 1996.
Rodriguez, R. and F. Bermejo, Tetrahedron Letters 37: 5581-5584, 1996.
Keck, G. E. and D.R. Romer, J. Org. Chem. 58: 6083-6089, 1993.
Kim Y.G., and J.K. Cha, Tetrahedron Letters, 30:5721-5724, 1989.
Tadano, K. et al, J. Org Chem,. 53:5209-5215, 1988.
Tadano, K., et al, Bull Chem. Soc. Jpn. 59: 3885-3892, 1986.
Tadano, K., et al, Bull. Chem. Soc. Jpn., 60:3667-3671, 1987.
Honda, T. et al, Chem. Soc. Perkin Trans. 1, p. 2091, 1994.
Suami, T. et al, Chemistry Letters, pp. 513-516, 1984.
Hembre, E.J. and W. H. Pearson, Tetrahedron 53: 11021-11032, 1997.
Fleet, G.W.J. et al., Tetrahedron Letters 26: 3127-3130, 1985.
Fleet, G.W.J. et al, Tetrahedron 44:2649, 1988.
Demetriou M. et al, J. Cell Biol. 130:383-392, 1995.
Dennis et al., Oncogene 4:853-860, 1998.
Bennett R.B. et al, J. Org. Am. Chem. Soc. 111:2580-2582, 1989.
The Alkaloids, vol. 44, Chapter 3, Simple Indolizidine Alkaloids, Hiroki Takahata and Takefumi Momose, 1993, Academic Press.
J. Am. Chem. Soc., Enantiomerically Pure Polyhydroxylated Acyliminium Ions, Synthesis of the Glycosidase Inhibitors (-) Swainsonine and (+) Castanospermine, Scott A. Miller and Richard Chamberlin, 1990, 112, pp. 8100-8112.
J. Org. Chem, A Practical Synthesis of (-) Swainsonine, William H. Pearson and Erik J. Hembre, 1996, 61, pp. 7217-7221.
Enantiospecific Syntheses of Leukotrienes C.sub.4, D.sub.4, and E.sub.4 and [14,15-.sup.3 H.sub.2 ] Leukotriene E.sub.4 Dimethyl Ester, Cohen et al, 1983 American Chemical Society.
2,3-0-Isopropylidene-D-Erythronolactone, Cohen et al., Org. Synth., (1985), 63, pp. 127-135.
The Chemistry of Castanospermine, Part IV.sup.1 : Synthetic Modifications at C-8. Furneaux et al., Tetrahdron vol. 51, No. 46, pp. 12611-12630, 1995.
Synthesis of Novel Glycosidase-Inhibitory Hydroxymethyl-Substituted Polyhydroxylated Indolizidines: Ring-Expanded Analogs of the Pyrrolizidine Alkaloids Alexine and Australine, Pearson et al., J. Org. Chem., 1996, 61, pp. 5546-5556.
Synthesis of the Mannosidase Inhibitors Swainsonine and 1,4-Dideoyx-1,4-Imino-D-Mannitol and of the Ring Contracted Swainsonine (1S,2R,7R,7aR)-1,2,7-Trihydroxypyrrolidine and (1S,2R,7S,7aR)-1,2,7-Trihydroxypyrrolizidine, Carpenter et al., Tetrahedron Letters, vol. 30, No. 51, pp. 7261-7264, 1989.
Carver Jeremy
Dennis James
Marino-Albernas Jose
Shah Rajan
Tropper Francois
Davis Zinna Northington
GlycoDesign
LandOfFree
3, 5, and/or 6 substituted analogues of swainsonine processes fo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3, 5, and/or 6 substituted analogues of swainsonine processes fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3, 5, and/or 6 substituted analogues of swainsonine processes fo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1176887